Annual Results 2023

Cicor Technologies Ltd.

March 6, 2024

Alexander Hagemann (CEO)

Peter Neumann (CFO)

March 6, 2024

Disclaimer

The information in this presentation does not constitute an offer or invitation and may not be construed as a recommendation by us to purchase, hold or sell shares of Cicor Technologies Ltd.

This information or any copy thereof may not be sent or taken to or distributed in any jurisdiction in which such transmission or distribution is unlawful. This document may contain certain 'forward-looking' statements. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Actual outcomes and results may differ materially from any outcomes or results expressed or implied by such forward-looking statements.

2

Alexander Hagemann

The Cicor Group

3

Electronification of everything

"Cicor inside" in three core markets

Medical

Industrial

29% of sales in 2023

39% of sales in 2023

Aerospace & Defence

16% of sales in 2023

Cicor helps improve global healthcare by the development and manufacture of applications such as hearing aids, surgical robots or smart drug delivery systems

Cicor is at the forefront of technology, driving miniaturization and automation in areas such as robotics, sensors, control systems and semiconductor equipment

Solutions from Cicor in aircrafts, satellites and defense systems ensure safety, reliability and communication at land, sea, in the skies and beyond

4

The Cicor Group - Facts and figures

High-tech Electronics CDMO*

Sales growth FY 2023

EBITDA margin FY 2023

24.5% to CHF 389.9M

11.6%

Organic growth of 11.1%

Sales to strategic marketsBook-to-bill rate FY 2023

84%

1.03

Industrial, Medical,

Aerospace & Defence

15

2,551

Production sites, resilient setup in Europe and Asia (December 31, 2023)

Cicor employees (December 31, 2023)

*) CDMO: Contract Development and Manufacturing Organization, also referenced as Electronics Manufacturing Services (EMS)

5

Contract design and manufacturing organisation - CDMO

One stop shop - creating strategic partnerships with customers

6

Global footprint

Close to customers and competitive

7

Alexander Hagemann

Cicor in 2023

8

Cicor in 2023

Highlights 2023

New record figures for order intake, sales and earnings

Continued positive book-to-bill ratio

Focus on medical, industrial, and aerospace & defence markets

Acquired businesses delivered above expectations

Strategic Partnership with Clayens

M&A fueled and organic growth continue in 2024

9

Cicor in 2023

Further strengthening of target markets: Industrial, Medical, A&D

Sales by industry

Sales by region

10

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Cicor Technologies SA published this content on 06 March 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 March 2024 12:14:29 UTC.